Clinical Trials Browser

Phase 1 × Unknown × Temozolomide × Clear all

NCT01107522 2025-09-09

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Phase 1 Unknown

Glioblastoma, Glioma

NCT05700955 2023-01-26

Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma

Phase 1 Unknown

Glioblastoma

NCT04385173 2022-12-28

Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma

Phase 1 Unknown

Glioblastoma

NCT03463733 2020-10-08

HUTMZ

Phase 1 Unknown

Glioblastoma, Glioma

NCT03687034 2019-02-26

A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma

Phase 1 Unknown

Glioblastoma

NCT00516607 2015-02-10

Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas

Phase 1 Unknown

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00003747 2013-09-20

Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma

Phase 1 Unknown

Melanoma

NCT00016055 2013-09-20

Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma

Phase 1 Unknown

Melanoma

NCT00409383 2011-11-07

Abraxane and Temodar Plus Genasense in Advanced Melanoma

Phase 1 Unknown

Melanoma

NCT00768911 2010-10-27

CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme

Phase 1 Unknown

Glioblastoma